Impact of extracorporeal haemoadsorption during prolonged cardiopulmonary bypass on the incidence of acute kidney injury
- PMID: 38888547
- PMCID: PMC11185140
- DOI: 10.1051/ject/2024004
Impact of extracorporeal haemoadsorption during prolonged cardiopulmonary bypass on the incidence of acute kidney injury
Abstract
The usage of cardiopulmonary bypass (CPB) in cardiothoracic surgery contributes to the activation of the inflammatory response. In certain cases, the systemic inflammatory response may be immoderate, leading to organ dysfunction, such as acute renal failure or multiorgan dysfunction. This study aimed to examine the effect of haemoadsorption (HA) therapy on inflammatory markers and renal damage indices during cardiopulmonary bypass and in the early postoperative period. We conducted a retrospective analysis of prospectively collected data in a single tertiary care center on patients operated between January 2021 and May 2022. The levels of inflammatory markers and renal parameters in blood samples (Interleukin (IL) 6, C-reactive protein (CRP), white blood cells, lactate, procalcitonin (PCT), and NT-proBNP, urea, creatinine, glomerular filtration rate (GFR), mechanical ventilation days and intensive care unit (ICU) days) were compared between the three groups. Data from the Jafron HA 330 (n = 20) and CytoSorb300 (n = 20) groups were compared with those from the control group (n = 20). All patients underwent cardiopulmonary bypass for more than 120 min. Baseline patient characteristics were similar in all three groups. Acute kidney injury (AKI) was diagnosed in 17 patients (28.3%); seven patients were in the Jafron HA 330, two in the CytoSorb300, and eight in the control group. We found that IL1α, IL 6, IL8, Lactate dehydrogenase, PCT, NT-proBNP, CRP, Leukocyte, and TNFα had no significant or clinical difference between the CytoSorb 300 and Jafron HA 330 adsorber groups. Our results indicate that haemoadsorption therapy does not significantly reduce the risk of AKI after prolonged CPB, but decreases the need for renal replacement therapy.
Keywords: Acute kidney injury; Haemoadsorption; Prolonged cardiopulmonary bypass; Systemic inflammatory response syndrome.
© The Author(s), published by EDP Sciences, 2024.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.Crit Care. 2019 Apr 3;23(1):108. doi: 10.1186/s13054-019-2399-4. Crit Care. 2019. PMID: 30944029 Free PMC article.
-
Use of intraoperative haemoadsorption in patients undergoing heart transplantation: a proof-of-concept randomized trial.ESC Heart Fail. 2024 Apr;11(2):772-782. doi: 10.1002/ehf2.14632. Epub 2023 Dec 19. ESC Heart Fail. 2024. PMID: 38111338 Free PMC article. Clinical Trial.
-
Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery.Ann Thorac Surg. 2009 Aug;88(2):529-35. doi: 10.1016/j.athoracsur.2009.03.072. Ann Thorac Surg. 2009. PMID: 19632407
-
Use of Cytokine Filters During Cardiopulmonary Bypass: Systematic Review and Meta-Analysis.Heart Lung Circ. 2022 Nov;31(11):1493-1503. doi: 10.1016/j.hlc.2022.07.015. Epub 2022 Aug 27. Heart Lung Circ. 2022. PMID: 36041987 Review.
-
Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies.Am J Kidney Dis. 2015 Feb;65(2):283-93. doi: 10.1053/j.ajkd.2014.09.008. Epub 2014 Nov 5. Am J Kidney Dis. 2015. PMID: 25445101 Review.
References
-
- Quaniers JM, Leruth J, Albert A, Limet RR, Defraigne J-O. Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit. Ann Thorac Surg 2006;81(5):1683–1690. - PubMed
-
- Melek FE, Baroncini LAV, Repka JCD, Nascimento CS, PrécomaPrécoma DB. Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation. Rev Bras Cir Cardiovas 2012;27(1):61–65. - PubMed
-
- Clive Landis R, Murkin JM, Stump DA, et al. Consensus statement: Minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum 2010;13:E116–E123. - PubMed
-
- Rubens FD, Nathan H, Labow R, et al. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 2005;79(2):655–665. - PubMed
-
- He Z, Lu H, Jian X, et al. The efficacy of resin hemoperfusion cartridge on inflammatory responses during adult cardiopulmonary bypass. Blood Purif 2022;51(1):31–37. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous